1. Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2

   • J. Saarinen
   • R. Harvima
   • I. Harvima

   Pharmacodynamics 08 March 2001 Pages: 1 - 4

2. Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics

   • C.M.E. Tranfa
   • A. Vatrella
   • S.A. Marsico

   Pharmacodynamics 21 March 2001 Pages: 5 - 9

3. Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

   • Collet Dandara
   • Collen Mutowembwa Masimirembwa
   • Julia Anne Hasler

   Pharmacokinetics and Disposition 28 March 2001 Pages: 11 - 17

4. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis

   • Fumihiro Suematsu
   • Eiji Yukawa
   • Yoshinobu Goto

   Pharmacokinetics and Disposition 28 March 2001 Pages: 19 - 24

5. The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers

   • R.A. Faaij
   • J.M.T. van Griensven
   • A.F. Cohen

   Pharmacokinetics and Disposition 28 March 2001 Pages: 25 - 29

6. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine

   • Gina M. Giancarlo
   • Karthik Venkatakrishnan
   • David J. Greenblatt

   Pharmacokinetics and Disposition 21 March 2001 Pages: 31 - 36

7. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole

   • Kari T. Kivistö
   • Jun-Sheng Wang
   • Pertti J. Neuvonen

   Pharmacokinetics and Disposition 28 March 2001 Pages: 37 - 42

8. Thiopurine methyltransferase activity in the Jewish population of Israel

   • A. Lowenthal
   • N. Meyerstein
   • Z. Ben-Zvi

   Pharmacokinetics and Disposition 17 March 2001 Pages: 43 - 46

9. High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population.

   • Elena García-Martín
   • Carmen Martínez
   • José A.G. Agúndez

   Pharmacokinetics and Disposition 15 March 2001 Pages: 47 - 49

10. Genotype–phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects

    • A.M. Rossi
    • M. Bianchi
    • G.M. Pacifici

    Pharmacokinetics and Disposition 06 March 2001 Pages: 51 - 54

11. The effect of community-acquired pneumonia on plasma esterases in older people

    • Khaled Abou-Hatab
    • Kandasamy Ganeshalingam
    • Kenneth Woodhouse

    Pharmacokinetics and Disposition 21 February 2001 Pages: 55 - 60

12. Anticoagulant treatment of patients in Swedish primary health care

    • P.E. Wändell

    Pharmacoepidemiology and Prescription 22 February 2001 Pages: 61 - 64

13. Prescribing, prescription costs and adherence to formulary committee recommendations: long-term differences between physicians in public and private care

    • Anders Håkansson
    • Henry Andersson
    • Arne Melander

    Pharmacoepidemiology and Prescription 14 March 2001 Pages: 65 - 70

14. Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population

    • Juan Merlo
    • Kristian Broms
    • Arne Melander

    Pharmacoepidemiology and Prescription 15 March 2001 Pages: 71 - 75

15. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study

    • Takanori Miura
    • Ryoji Kojima
    • Yoshio Suzuki

    Pharmacoepidemiology and Prescription 17 March 2001 Pages: 77 - 83

16. Influence of diltiazem on the pharmacokinetics of amlodipine in elderly hypertensive patients

    • M. Sasaki
    • A. Maeda
    • A. Fujimura

    Letter to the Editors 22 February 2001 Pages: 85 - 86

17. Prednisolone-containing ointment sold as Traditional Chinese Medicine

    • J. Martens-Lobenhoffer
    • F.P. Meyer

    Letter to the Editors 28 March 2001 Pages: 87 - 88

18. The use of evidence in pharmacovigilance

    • J.A. Arnaiz
    • X. Carné
    • A. Trilla

    Debate Article 30 March 2001 Pages: 89 - 91